Updated Jul 16, 2026 · Last SEC filing 2026-07-13
Indivior Pharmaceuticals, Inc. (INDV) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-13. 3 Form 8-K material event filings were reported by INDV in the last 90 days. 4 Form 144 notices of proposed sale were filed for INDV stock. InsiderAlpha tracks every INDV SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001625297 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-13 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Heidbreder Christian | Chief Scientific Officer | S — Open-market sale [10b5-1] | 18.6K | $41.14 | $765K | SEC | |
| Ciaffoni Joseph | Chief Executive Officer | F — Tax withholding / forfeiture | 612.5K | $38.32 | $23.47M | SEC | |
| Ciaffoni Joseph | Chief Executive Officer | M — Option exercise | 1.27M | — | — | SEC | |
| Heidbreder Christian | Chief Scientific Officer | S — Open-market sale | 18.6K | $38.06 | $707K | SEC | |
| Preblick Ryan | Chief Financial Officer | S — Open-market sale | 36.0K | $37.70 | $1.36M | SEC | |
| Humphreys Keith | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| Thompson Juliet | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| NINIVAGGI DANIEL A | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| Stejbach Mark | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| Ryan Barbara | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| Wheadon David E. | Director | A — Grant or award | 10.4K | $0.00 | — | SEC | |
| Kingsley Stuart A | Director | A — Grant or award | 6.5K | $0.00 | — | SEC | |
| Thompson Juliet | Director | F — Tax withholding / forfeiture | 1.1K | $38.28 | $43K | SEC | |
| Preblick Ryan | Chief Financial Officer | M — Option exercise | 6.3K | — | — | SEC | |
| Preblick Ryan | Chief Financial Officer | F — Tax withholding / forfeiture | 2.8K | $31.11 | $88K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Indivior Pharmaceuticals, Inc. (INDV). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Ciaffoni Joseph | 3 | $23.47M |
| Thompson Juliet | 2 | $43K |
| Heidbreder Christian | 2 | $1.47M |
| Humphreys Keith | 1 | — |
| NINIVAGGI DANIEL A | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in INDV insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live INDV dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.